Inventor · disambiguated record
Elizabeth Mcnally
Also filed as: MCNALLY ELIZABETH · MCNALLY ELIZABETH M
5 granted patents·32 pending applications·9 citations·filing 2013–2025
78Inventor score
Files withUNIV CHICAGO19IKAIKA THERAPEUTICS LLC7IKAIKA THERAPEUTICS INC4UNIV NORTHWESTERN4KAIKA THERAPEUTICS INC1
Top patents by PatentIndex Score
37 records- 0189US2024327844A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 0287US2024076670A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2023·Application pending·0 cites
- 0383US2024301428A1Compositions and methods for correcting limb girdle muscular dystrophy type 2c using exon skippingUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 0483US2023183700A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2022·Application pending·0 cites
- 0582US9777271B2Antisense polynucleotides to induce exon skipping and methods of treating dystrophiesUNIV CHICAGO·Filed 2016·Granted Oct 3, 2017·2 cites·12 claims
- 0681US10273483B2Compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon skippingUNIV CHICAGO·Filed 2016·Granted Apr 30, 2019·2 cites·24 claims
- 0780US2022251559A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2022·Application pending·0 cites
- 0877US2021403910A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2021·Application pending·0 cites
- 0977US2025109197A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)IKAIKA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1076US9499817B2Antisense polynucleotides to induce exon skipping and methods of treating dystrophiesMCNALLY ELIZABETH·Filed 2013·Granted Nov 22, 2016·3 cites·29 claims
- 1176US2023167452A1Compositions and methods for correcting limb girdle muscular dystrophy type 2c using exon skippingUNIV CHICAGO·Filed 2022·Application pending·0 cites
- 1276US2025179495A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2025·Application pending·0 cites
- 1376US2025346664A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)KAIKA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1476US2024287171A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)IKAIKA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1575US2021147845A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2021·Application pending·0 cites
- 1674US2022119820A1Compositions and methods for correcting limb girdle muscular dystrophy type 2c using exon skippingUNIV CHICAGO·Filed 2022·Application pending·0 cites
- 1772US2020291403A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2020·Application pending·0 cites
- 1870US2020040340A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2019·Application pending·0 cites
- 1969US10801029B2Compositions and methods for correcting limb girdle muscular dystrophy type 2C using exon skippingUNIV CHICAGO·Filed 2019·Granted Oct 13, 2020·0 cites·21 claims
- 2069US2019194659A1Antisense polynucleotides to induce exon skipping and method of treating dystrophiesUNIV CHICAGO·Filed 2019·Application pending·0 cites
- 2169US2023235044A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)IKAIKA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2268US2021032631A1Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon SkippingUNIV CHICAGO·Filed 2020·Application pending·0 cites
- 2367US2018327743A1Antisense Polynucleotides to Induce Exon Skipping and Method of Treating DystrophiesUNIV CHICAGO·Filed 2018·Application pending·0 cites
- 2466US9873739B2Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4)IKAIKA THERAPEUTICS LLC·Filed 2013·Granted Jan 23, 2018·2 cites·12 claims
- 2566US2022089717A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)IKAIKA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2665US2018037889A1Antisense polynucleotides to induce exon skipping and methods of treating dystrophiesUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 2765US2025387516A1Materials and methods for modifying expression of myosin heavy chain genesUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 2862US2021238274A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)IKAIKA THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2961US2020123247A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)IKAIKA THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 3060US2020385457A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)IKAIKA THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 3156US2019256589A1Mitigating Tissue Damage and Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (LTBP4)IKAIKA THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 3256US2025195609A1Use of annexins in preventing and treating cardiac neuronal cell membrane injury and diseaseUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 3356US2024026320A1Materials and methods for modifying expression of myosin heavy chain genesNORTHWESTTERN UNIV·Filed 2021·Application pending·0 cites
- 3454US2019002557A1Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)IKAIKA THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 3553US2018134785A1Mitigating Tissue Damage and Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (LTBP4)IKAIKA THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 3652US2022062299A1Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorderUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
- 3744US2022143136A1Use of annexins in preventing and treating muscle membrane injuryUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elizabeth Mcnally files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →